All News | FDA

Advertising & Promotion

Feb 3, 2020
California Court Requires J&J To Pay $344 Million Over ‘False and Deceptive’ Marketing of Pelvic Mesh Products
Jan 29, 2020
OPDP Announces Research Projects on Product Endorsements and Proprietary Names
Jan 28, 2020
District Court in Boston Hands Down Sentences — Including Prison Time — to Seven Insys Executives
Jan 19, 2020
Endo Settles with Oklahoma Over Opioid Marketing
Jan 15, 2020
Former Insys Executive Sentenced to 33 Months in Prison for Role in Prior Authorization Scheme
Jan 8, 2020
Teva Agrees To Pay $54 Million To Settle Qui Tam Case Involving Speaker Program Allegations
Jan 7, 2020
Marketers Need New Mindsets, Skillsets and Toolkits
Jan 4, 2020
Washington State Sues J&J Over Janssen Opioid Marketing
Dec 31, 2019
NAD Refers Device Ad Claims to FDA, FTC
Dec 26, 2019
Former Aegerion Sales Rep Convicted for Wire Fraud, Identity Theft Used in Insurance Fraud Scheme

Good Clinical Practice

U.S. Food Labeling

Jun 13,2018
Bill Calls for Labeling Based on Science
Jun 6,2018
Webinar Provides Stakeholders Overview of BE Proposal
May 30,2018
Court Rules Bottled Water Mislabeling Complaint Is Preempted by FD&C Act
May 24,2018
Recent Court Decisions Dismiss Suits Questioning Labeling of ‘Diet’ Sodas
May 12,2018
USDA Releases Proposed GMO Labeling Rule
May 9,2018
FDA Provides Additional Guidance as Menu Labeling ‘Goes Live’
May 2,2018
AMS Proposes Addition, Reclassification of Items on Organic Substances List
Apr 26,2018
Olive Oil Settlement Is Part of Trend in Class Action Litigation
Apr 18,2018
News in Brief
Apr 11,2018
Creamery Says Skim Milk Labeling Regs Violate First Amendment

FDA Regulation & Enforcement

Oct 25, 2023
FDA Outlines How It Conducts Remote Interactive Evaluations of Drug and Bioresearch Facilities
Oct 23, 2023
FDA Moving Ahead With FOPL Priority
Oct 21, 2023
Bill Requiring Price Disclosure in DTC Ads Introduced in House
Oct 18, 2023
OPDP Researchers To Examine Adherence and Preference Claims
Oct 16, 2023
Former CEO Pleads Guilty to Marketing Migraine Treatment Device Without FDA’s Authorization
Oct 11, 2023
Florida Man Pleads Guilty to Conspiring To Divert HIV Meds, Other Drugs Worth Up to $25 Million
Oct 11, 2023
FDA ‘Unsatisfied’ With Recall of Philips Respironics Devices; Senator Calls for Enforcement Action
Oct 10, 2023
Can a Brand Name Deceive Consumers?
Oct 4, 2023
Genomic Test Provider To Pay $32.5 Million To Resolve Allegations of Improperly Billing Medicare
Oct 4, 2023
Petitions Over Compliance Guidance and Notice of Penalty Offenses Filed With FTC

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.